Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:TNDM
- CUSIP: N/A
- Web: www.tandemdiabetes.com
Capitalization:- Market Cap: $39.93 million
- Outstanding Shares: 49,839,000
Average Prices:- 50 Day Moving Avg: $0.87
- 200 Day Moving Avg: $1.69
- 52 Week Range: $0.76 - $8.81
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.62
- P/E Growth: -0.0100
Sales & Book Value:- Annual Revenue: $83.17 million
- Price / Sales: 0.48
- Book Value: ($0.04) per share
- Price / Book: -21.65
Profitability:- EBIDTA: ($74,460,000.00)
- Net Margins: -104.31%
- Return on Equity: -1,177.11%
- Return on Assets: -81.72%
Debt:- Debt-to-Equity Ratio: -39.66%
- Current Ratio: 2.74%
- Quick Ratio: 1.92%
Misc:- Average Volume: 605,909 shs.
- Beta: 0.62
- Short Ratio: 11.61
Frequently Asked Questions for Tandem Diabetes Care (NASDAQ:TNDM)
What is Tandem Diabetes Care's stock symbol?
Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."
How were Tandem Diabetes Care's earnings last quarter?
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) released its earnings results on Thursday, April, 27th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.66) by $0.09. The firm had revenue of $17.50 million for the quarter, compared to analyst estimates of $15.72 million. Tandem Diabetes Care had a negative return on equity of 1,177.11% and a negative net margin of 104.31%. Tandem Diabetes Care's revenue was down 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.68) earnings per share. View Tandem Diabetes Care's Earnings History.
When will Tandem Diabetes Care make its next earnings announcement?
Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2017?
9 brokers have issued 1 year price targets for Tandem Diabetes Care's stock. Their forecasts range from $1.50 to $11.00. On average, they expect Tandem Diabetes Care's share price to reach $5.08 in the next year. View Analyst Ratings for Tandem Diabetes Care.
Are investors shorting Tandem Diabetes Care?
Tandem Diabetes Care saw a increase in short interest in the month of May. As of May 15th, there was short interest totalling 2,838,888 shares, an increase of 14.4% from the April 28th total of 2,481,723 shares. Based on an average daily volume of 283,144 shares, the days-to-cover ratio is currently 10.0 days.
Who are some of Tandem Diabetes Care's key competitors?
Some companies that are related to Tandem Diabetes Care include Cytori Therapeutics (CYTX), Bioquell plc (BQE), Capnia (SLNO), Surgical Innovations Group Plc (SUN), Alliqua BioMedical (ALQA), Lombard Medical (EVAR), InspireMD (NSPR), NeuroMetrix (NURO), CareFusion (CFN), Covidien Ltd (COV), CRH Medical Corp (CRHM), Great Basin Scientific (GBSN) and LDR Holding Corp (LDRH).
Who are Tandem Diabetes Care's key executives?
Tandem Diabetes Care's management team includes the folowing people:
- Dick P. Allen, Chairman of the Board
- Kim D. Blickenstaff, President, Chief Executive Officer, Board Member
- John Cajigas, Chief Financial Officer, Treasurer
- John F. Sheridan, Chief Operating Officer, Executive Vice President
- Brian Hansen, Chief Commercial Officer, Executive Vice President
- Susan M. Morrison, Chief Administrative Officer
- Lori Gildea, Vice President - Sales
- David B. Berger Esq., General Counsel, Corporate Secretary
- Edward L. Cahill, Independent Director
- Fred E. Cohen Ph.D., M.D., Independent Director
Who owns Tandem Diabetes Care stock?
Tandem Diabetes Care's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Frontier Capital Management Co. LLC (9.84%), TPG Group Holdings SBS Advisors Inc. (5.01%), Vanguard Group Inc. (2.41%), Bank of America Corp DE (1.73%), Paulson & CO. Inc. (1.00%) and Granite Investment Partners LLC (1.43%). Company insiders that own Tandem Diabetes Care stock include Dick Allen, John F Sheridan and Kim D Blickenstaff. View Institutional Ownership Trends for Tandem Diabetes Care.
Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?
Who bought Tandem Diabetes Care stock? Who is buying Tandem Diabetes Care stock?
Tandem Diabetes Care's stock was purchased by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Vanguard Group Inc., Paulson & CO. Inc., Bank of America Corp DE, Russell Investments Group Ltd., Falcon Point Capital LLC, Group One Trading L.P. and Keybank National Association OH. Company insiders that have bought Tandem Diabetes Care stock in the last two years include Dick Allen and Kim D Blickenstaff. View Insider Buying and Selling for Tandem Diabetes Care.
How do I buy Tandem Diabetes Care stock?
Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tandem Diabetes Care's stock price today?
One share of Tandem Diabetes Care stock can currently be purchased for approximately $0.80.
MarketBeat Community Rating for Tandem Diabetes Care (NASDAQ TNDM)MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Tandem Diabetes Care (NASDAQ:TNDM) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 5 Hold Ratings, 4 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.44) |
| Consensus Price Target: | $5.08 (534.54% upside) |
Analysts' Ratings History for Tandem Diabetes Care (NASDAQ:TNDM)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 5/3/2017 | B. Riley | Reiterated Rating | Neutral | $1.50 | Medium |  |
| 4/10/2017 | Cowen and Company | Downgrade | Outperform -> Market Perform | $1.50 | Medium | |
| 3/30/2017 | Wedbush | Reiterated Rating | Outperform | $11.00 | Low | |
| 3/30/2017 | Piper Jaffray Companies | Reiterated Rating | Neutral -> Neutral | | Medium | |
| 3/9/2017 | Northcoast Research | Reiterated Rating | Buy | | N/A | |
| 11/2/2016 | Deutsche Bank AG | Lower Price Target | Buy | $14.00 -> $9.00 | N/A | |
| 11/2/2016 | Feltl & Co. | Downgrade | Strong-Buy -> Buy | | N/A | |
| 11/2/2016 | Robert W. Baird | Downgrade | Outperform -> Neutral | $11.00 -> $4.00 | N/A | |
| 11/2/2016 | Stifel Nicolaus | Downgrade | Buy -> Hold | $15.00 -> $3.50 | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Neutral | | N/A | |
| 3/24/2016 | Bank of America Corporation | Downgrade | Neutral -> Underperform | | N/A | |
| 10/21/2015 | William Blair | Reiterated Rating | Market Perform | | N/A | |
(Data available from 6/27/2015 forward)
Earnings History for Tandem Diabetes Care (NASDAQ:TNDM)Earnings History by Quarter for Tandem Diabetes Care (NASDAQ TNDM)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/26/2017 | | | | | | | | |
| 4/27/2017 | Q1 2017 | ($0.66) | ($0.75) | $15.72 million | $17.50 million | View | N/A | |
| 3/8/2017 | Q4 2016 | ($0.65) | ($0.48) | $22.75 million | $24.80 million | View | Listen | |
| 7/28/2016 | Q216 | ($0.65) | ($0.60) | $23.08 million | $23.00 million | View | Listen | |
| 4/28/2016 | Q116 | ($0.69) | ($0.68) | $17.67 million | $20.06 million | View | N/A | |
| 2/24/2016 | Q415 | ($0.51) | ($0.40) | $29.17 million | $29.10 million | View | Listen | |
| 10/29/2015 | Q3 | ($0.80) | ($0.65) | $12.58 million | $15.70 million | View | Listen | |
| 7/30/2015 | Q215 | ($0.71) | ($0.65) | $14.92 million | $15.70 million | View | Listen | |
| 4/30/2015 | Q115 | ($0.79) | ($0.83) | $12.19 million | $12.30 million | View | N/A | |
| 2/24/2015 | Q414 | ($0.81) | ($0.78) | $17.16 million | $17.90 million | View | N/A | |
| 11/6/2014 | Q314 | ($0.82) | ($0.85) | $13.60 million | $13.50 million | View | N/A | |
| 7/31/2014 | Q214 | ($0.91) | ($0.83) | $10.36 million | $10.26 million | View | N/A | |
| 5/6/2014 | Q1 | ($0.69) | ($0.96) | $8.24 million | $8.10 million | View | N/A | |
| 11/8/2011 | | $0.25 | $0.18 | | | View | N/A | |
| 8/9/2011 | | $0.26 | $0.20 | | | View | N/A | |
| 5/10/2011 | | $0.24 | $0.24 | | | View | N/A | |
| 3/14/2011 | | $0.29 | $0.18 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Tandem Diabetes Care (NASDAQ:TNDM)2017 EPS Consensus Estimate: ($1.79)
2018 EPS Consensus Estimate: ($1.17)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | ($0.81) | ($0.62) | ($0.71) |
| Q2 2017 | 4 | ($0.63) | ($0.37) | ($0.46) |
| Q3 2017 | 4 | ($0.50) | ($0.33) | ($0.38) |
| Q4 2017 | 5 | ($0.28) | ($0.21) | ($0.25) |
| Q1 2018 | 2 | ($0.34) | ($0.34) | ($0.34) |
| Q2 2018 | 2 | ($0.34) | ($0.28) | ($0.31) |
| Q3 2018 | 2 | ($0.28) | ($0.28) | ($0.28) |
| Q4 2018 | 2 | ($0.28) | ($0.20) | ($0.24) |
(Data provided by Zacks Investment Research)
Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Tandem Diabetes Care (NASDAQ:TNDM)Insider Ownership Percentage: 37.10%
Institutional Ownership Percentage: 73.50%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/23/2017 | Kim D Blickenstaff | CEO | Buy | 1,600,000 | $1.25 | $2,000,000.00 | |
| 8/1/2016 | John F Sheridan | EVP | Sell | 15,000 | $6.52 | $97,800.00 | |
| 5/2/2016 | John F Sheridan | COO | Sell | 2,000 | $10.61 | $21,220.00 | |
| 4/22/2016 | John F Sheridan | COO | Sell | 2,000 | $10.00 | $20,000.00 | |
| 3/7/2016 | John F Sheridan | COO | Sell | 4,000 | $10.01 | $40,040.00 | |
| 2/26/2016 | Dick Allen | Director | Buy | 10,000 | $8.24 | $82,400.00 | |
| 12/1/2015 | John F. Sheridan | COO | Sell | 2,000 | $10.14 | $20,280.00 | |
| 11/2/2015 | John F. Sheridan | COO | Sell | 4,000 | $10.00 | $40,000.00 | |
| 9/14/2015 | John F. Sheridan | COO | Sell | 2,000 | $12.51 | $25,020.00 | |
| 5/1/2015 | John F Sheridan | COO | Sell | 2,000 | $13.72 | $27,440.00 | |
| 4/1/2015 | John F Sheridan | COO | Sell | 2,000 | $12.47 | $24,940.00 | |
| 2/2/2015 | John F Sheridan | COO | Sell | 2,000 | $12.06 | $24,120.00 | |
| 1/2/2015 | John F Sheridan | COO | Sell | 2,000 | $12.75 | $25,500.00 | |
| 12/12/2014 | Dick Allen | Director | Buy | 10,000 | $11.95 | $119,500.00 | |
| 12/1/2014 | John F Sheridan | COO | Sell | 2,000 | $13.55 | $27,100.00 | |
| 11/3/2014 | John F Sheridan | COO | Sell | 2,000 | $16.00 | $32,000.00 | |
| 10/1/2014 | John F Sheridan | COO | Sell | 2,000 | $13.07 | $26,140.00 | |
| 9/2/2014 | John F Sheridan | COO | Sell | 2,000 | $13.99 | $27,980.00 | |
| 8/1/2014 | John F Sheridan | COO | Sell | 2,000 | $15.04 | $30,080.00 | |
| 7/1/2014 | John F Sheridan | COO | Sell | 2,000 | $16.42 | $32,840.00 | |
| 6/18/2014 | John F Sheridan | COO | Sell | 2,000 | $16.75 | $33,500.00 | |
| 11/13/2013 | David B Berger | General Counsel | Buy | 2,000 | $15.00 | $30,000.00 | |
| 11/13/2013 | Hlm Venture Partners Ii, L.P. | Major Shareholder | Buy | 200,000 | $15.00 | $3,000,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Tandem Diabetes Care (NASDAQ:TNDM)
Latest Headlines for Tandem Diabetes Care (NASDAQ:TNDM)
| Source: |
|
| Date | Headline |
|---|
 | Tandem Diabetes Care, Inc. (TNDM) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 20 at 8:34 AM |
 | Tandem Diabetes Care Presents Findings from Predictive Low Glucose Suspend (PLGS) Feasibility Study and Announces Approval of Investigational Device Exemption (IDE) for Pivotal Trial
finance.yahoo.com - June 12 at 7:43 PM |
| $21.83 Million in Sales Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - June 11 at 10:02 AM |
| Analysts Expect Tandem Diabetes Care Inc (TNDM) to Announce -$0.49 EPS
www.americanbankingnews.com - June 9 at 7:40 AM |
| Tandem Diabetes Care Inc (TNDM) Short Interest Up 14.4% in May
www.americanbankingnews.com - June 5 at 8:40 AM |
| ETFs with exposure to Tandem Diabetes Care, Inc. : June 2, 2017
finance.yahoo.com - June 2 at 3:28 PM |
| Tandem Diabetes Care Inc (TNDM) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 26 at 8:51 AM |
| ETFs with exposure to Tandem Diabetes Care, Inc. : May 19, 2017
finance.yahoo.com - May 19 at 6:14 PM |
| Tandem Diabetes Care Inc (TNDM) Expected to Announce Quarterly Sales of $21.83 Million
www.americanbankingnews.com - May 14 at 8:45 AM |
| -$0.49 EPS Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - May 13 at 12:04 AM |
| ETFs with exposure to Tandem Diabetes Care, Inc. : May 8, 2017
finance.yahoo.com - May 8 at 7:45 PM |
| Somewhat Positive Media Coverage Somewhat Likely to Impact Tandem Diabetes Care (TNDM) Stock Price
www.americanbankingnews.com - May 3 at 8:36 PM |
| Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017
finance.yahoo.com - May 3 at 6:29 PM |
| Negative Media Coverage Very Likely to Impact Tandem Diabetes Care (TNDM) Share Price
www.americanbankingnews.com - April 30 at 7:48 AM |
| Tandem Diabetes Care Inc (TNDM) Receives "Neutral" Rating from B. Riley
www.americanbankingnews.com - April 30 at 12:33 AM |
| Edited Transcript of TNDM earnings conference call or presentation 27-Apr-17 8:30pm GMT
finance.yahoo.com - April 28 at 10:55 PM |
| Investor Network: Tandem Diabetes Care, Inc. to Host Earnings Call
finance.yahoo.com - April 28 at 2:44 AM |
| Tandem Diabetes Care Reports First Quarter 2017 Financial Results
finance.yahoo.com - April 28 at 2:44 AM |
| Tandem Diabetes Care Inc (TNDM) Releases Quarterly Earnings Results, Misses Expectations By $0.13 EPS
www.americanbankingnews.com - April 28 at 1:03 AM |
| Tandem Diabetes Care Inc (TNDM) Posts Earnings Results, Misses Expectations By $0.13 EPS
www.americanbankingnews.com - April 27 at 11:16 PM |
 | BRIEF-Tandem Diabetes Care reports Q1 loss per share $0.75
www.reuters.com - April 27 at 9:43 PM |
 | Tandem Diabetes reports 1Q loss
marketbeat.com - April 27 at 5:55 PM |
| Tandem Diabetes Care (TNDM) Receiving Somewhat Favorable Press Coverage, Study Shows
www.americanbankingnews.com - April 27 at 1:10 PM |
| ETFs with exposure to Tandem Diabetes Care, Inc. : April 26, 2017
finance.yahoo.com - April 26 at 4:43 PM |
| Tandem Diabetes Care Inc (TNDM) Expected to Announce Quarterly Sales of $16.12 Million
www.americanbankingnews.com - April 26 at 1:01 PM |
| Tandem Diabetes Care (TNDM) Receives Daily Media Impact Rating of 0.25
www.americanbankingnews.com - April 24 at 6:51 PM |
| -$0.66 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - April 24 at 10:38 AM |
| Tandem Diabetes Care to Present at the Deutsche Bank 42nd Annual Health Care Conference
finance.yahoo.com - April 19 at 9:13 PM |
| Tandem Diabetes Care (TNDM) Receiving Somewhat Negative News Coverage, Study Shows
www.americanbankingnews.com - April 17 at 2:40 PM |
| Tandem Diabetes Care (TNDM) Given News Impact Score of 0.32
www.americanbankingnews.com - April 14 at 4:53 PM |
| Tandem Diabetes Care Schedules First Quarter 2017 Earnings Press Release and Conference Call
finance.yahoo.com - April 13 at 8:06 PM |
| ETFs with exposure to Tandem Diabetes Care, Inc. : April 11, 2017
finance.yahoo.com - April 11 at 8:03 PM |
| Tandem Diabetes Care Launches New t:connect Diabetes Management Application Portal for Healthcare Providers
finance.yahoo.com - April 11 at 9:11 AM |
| Tandem Diabetes Care Inc (TNDM) Downgraded by Cowen and Company to "Market Perform"
www.americanbankingnews.com - April 10 at 12:35 PM |
| Wedbush Reiterates "Outperform" Rating for Tandem Diabetes Care Inc (TNDM)
www.americanbankingnews.com - April 5 at 9:01 AM |
| Tandem Diabetes Care Inc (TNDM) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 4 at 2:01 PM |
| Wedbush Weighs in on Tandem Diabetes Care Inc's Q1 2017 Earnings (TNDM)
www.americanbankingnews.com - April 3 at 7:32 AM |
| Tandem Diabetes Care Inc (TNDM) Earns Outperform Rating from Wedbush
www.americanbankingnews.com - March 30 at 4:31 PM |
| Tandem Diabetes Care Inc (TNDM) Coverage Initiated by Analysts at Piper Jaffray Companies
www.americanbankingnews.com - March 30 at 11:49 AM |
| Tandem Diabetes Care Inc (TNDM) Downgraded by B. Riley
www.americanbankingnews.com - March 30 at 12:04 AM |
| TANDEM DIABETES CARE INC Files SEC form 8-K, Other Events
biz.yahoo.com - March 28 at 8:10 PM |
 | Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge - Benzinga
www.benzinga.com - March 25 at 8:04 AM |
| Tandem Diabetes Care Inc (TNDM) Downgraded to Neutral at B. Riley
www.americanbankingnews.com - March 24 at 7:52 PM |
| BRIEF-Tandem Diabetes Care prices common stock offering of 18 mln shares
www.reuters.com - March 24 at 2:06 AM |
 | Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket
seekingalpha.com - March 24 at 2:06 AM |
 | Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock
us.rd.yahoo.com - March 24 at 2:06 AM |
| Implied Volatility Surging for Tandem (TNDM) Stock Options
us.rd.yahoo.com - March 24 at 2:06 AM |
| TANDEM DIABETES CARE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat
biz.yahoo.com - March 24 at 2:06 AM |
| Kim D. Blickenstaff Buys 1,600,000 Shares of Tandem Diabetes Care Inc (TNDM) Stock
www.americanbankingnews.com - March 23 at 10:35 PM |
| Tandem Diabetes files S-1 for follow-on stock offering; shares slip 23% premarket
seekingalpha.com - March 23 at 8:33 AM |
Tandem Diabetes Care (TNDM) Chart for Tuesday, June, 27, 2017
